Evidence map›Paper›PMID 24725938›Full record

ArticleVirology2014

The NS5A-binding heat shock proteins HSC70 and HSP70 play distinct roles in the hepatitis C viral life cycle.

Ronik Khachatoorian, Ekambaram Ganapathy, Yasaman Ahmadieh, Nicole Wheatley, Christopher Sundberg, Chun-Ling Jung, Vaithilingaraja Arumugaswami, Santanu Raychaudhuri, Asim Dasgupta, Samuel W French

Abstract read
In one paragraph

Article in Virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Role of Heat Shock Proteins (HSP70 and HSP90) in Viral Infection.International journal of molecular sciences · 2021
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Allosteric heat shock protein 70 inhibitors block hepatitis C virus assembly.International journal of antimicrobial agents · 2016
    Article
  18. Article
  19. Chaperones in hepatitis C virus infection.World journal of hepatology · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ronik KhachatoorianDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA, United States of America. Electronic address: RnKhch@ucla.edu.
Ekambaram GanapathyDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA, United States of America. Electronic address: GEkambaram@ucla.edu.
Yasaman AhmadiehDepartment of Chemistry and Biochemistry, University of California, Los Angeles, CA, United States of America. Electronic address: YasAhmadieh@ucla.edu.
Nicole WheatleyMolecular Biology Interdepartmental Ph.D. Program (MBIDP), Molecular Biology Institute, David Geffen School of Medicine at University of California, Los Angeles, CA, United States of America; Molecular Biology Institute, David Geffen School of Medicine at University of California, Los Angeles, CA, United States of America. Electronic address: Wheatley.NM@gmail.com.
Christopher SundbergDepartment of Human Genetics, David Geffen School of Medicine at University of California, Los Angeles, CA, United States of America. Electronic address: Christopher.Sundberg@gmail.com.
Chun-Ling JungDepartment of Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA, United States of America. Electronic address: CLJung@mednet.ucla.edu.
Vaithilingaraja ArumugaswamiDepartment of Molecular and Medical Pharmacology, David Geffen School of Medicine at University of California, Los Angeles, CA, United States of America; Department of Surgery, Regenerative Medicine Institute at Cedars-Sinai Medical Center, Los Angeles, CA, United States of America. Electronic address: Vaithi.Arumugaswami@cshs.org.
Santanu RaychaudhuriDepartment of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at University of California, Los Angeles, CA, United States of America. Electronic address: SRaychau@ucla.edu.
Asim DasguptaDepartment of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine at University of California, Los Angeles, CA, United States of America; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California, Los Angeles, CA, United States of America; UCLA AIDS Institute, David Geffen School of Medicine at University of California, Los Angeles, CA, United States of America. Electronic address: Dasgupta@ucla.edu.
Samuel W FrenchDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine at University of California, Los Angeles, CA, United States of America; Jonsson Comprehensive Cancer Center, David Geffen School of Medicine at University of California, Los Angeles, CA, United States of America; UCLA AIDS Institute, David Geffen School of Medicine at University of California, Los Angeles, CA, United States of America. Electronic address: SFrench@mednet.ucla.edu.
University of California, Los Angeles · USCedars-Sinai Medical Center · US

Funding

UCLA NIGMS T32 Program AssessmentT32GM007185 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TORRES, JORGE · 1985 to 2020
$21.7M
Pilot and Feasibility ProgramP30DK041301 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ROZENGURT, JUAN ENRIQUE · 1990 to 2019
$18.0M
Heat Shock Protein Synthesis Inhibitor Treatment of Hepatitis C Viral InfectionR01DK090794 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FRENCH, SAMUEL WHEELER · 2011 to 2015
$1.7M
The role of hepatitis C virus 5' untranslated region in virus morphogenesisR21AI084090 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DASGUPTA, ASIM · 2010 to 2011
$411k
NIAID NIH HHS AI084090NIAID NIH HHS R21 AI084090NIDDK NIH HHS P30 DK041301NIDDK NIH HHS R01 DK090794NIDDK NIH HHS R01DK090794NIGMS NIH HHS T32 GM007185PHS HHS CJX1-443835-WS-29646
6 · The paper itself

Abstract

We previously identified HSP70 and HSC70 in complex with NS5A in a proteomic screen. Here, coimmunoprecipitation studies confirmed NS5A/HSC70 complex formation during infection, and immunofluorescence studies showed NS5A and HSC70 to colocalize. Unlike HSP70, HSC70 knockdown did not decrease viral protein levels. Rather, intracellular infectious virion assembly was significantly impaired by HSC70 knockdown. We also discovered that both HSC70 nucleotide binding and substrate binding domains directly bind NS5A whereas only the HSP70 nucleotide binding domain does. Knockdown of both HSC70 and HSP70 demonstrated an additive reduction in virus production. This data suggests that HSC70 and HSP70 play discrete roles in the viral life cycle. Investigation of these different functions may facilitate developing of novel strategies that target host proteins to treat HCV infection.

Indexed as

Host-Pathogen InteractionsHepacivirusHSP70 Heat-Shock ProteinsHumansImmunoprecipitationMicroscopy, ConfocalProtein BindingRNA-Dependent RNA PolymeraseViral Nonstructural ProteinsVirus AssemblyVirus ReplicationHSP70 Heat-Shock ProteinsNS-5 protein, hepatitis C virusRNA-Dependent RNA PolymeraseViral Nonstructural ProteinsAssemblyHCVHSC70HSP70IRESNS5A

Identifiers

PMID24725938
PMCPMC4011396
OpenAlexW1972415146

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.